1:00 PM - 6:00 PM

9:00 AM - 4:00 PM

Viral infections are a major cause of disease, with enormous costs in morbidity/mortality and economic losses worldwide. Since only a few viral diseases can currently be prevented by vaccination, antiviral therapy is an essential instrument to control virus infections.
Antiviral pharmacology has evolved significantly over the past four decades and around 50 drugs have been approved for human use against viruses such as HIV, HSV, CMV, the influenza virus, HBV and HCV.
Our understanding has significantly progressed in the area of antivirals, particularly as for their mechanisms of action, pharmacokinetics, pharmacodynamics, pharmacogenomics and clinical implications, all of which contribute to optimizing their use.
The course aims to explore and elucidate these intricate pharmacological aspects of antiviral medications. It presents a unique opportunity for interdisciplinary cross-fertilization of ideas and incorporation of personalized medicine approaches in the areas of antivirals.
Combined as in-person and virtual participation to ensure a wide-reaching and inclusive engagement, the course brings together experts to discuss all aspects of the optimal use of current antiviral drugs and to focus on recent advances in
the clinical pharmacology of antiviral therapies.

The official language of the Course is English. There is no simultaneous interpretation.

HealthData Consulting S.r.l. 

via Morghen 27, 10143 Turin, Tel. +39 011 0267950 - Fax +39 011 0267954 - Mail segreteria@hdcons.it, P.IVA 01429280058, REA 1125824